Bridging the Gap between Bio-Pharmaceuticals,
CROs, Clinical Investigators and Trial Participants

“Patient-Centred Clinical Trials”

This workshop will bring in ideas from consumer-driven industries to discuss how Clinical Trials can become more ‘patient-centred’.

It is not uncommon to see a drop-out rate of 20-30% in trials with a longer follow-up period. And with less than 20% of clinical trials currently completed on time, largely due to patient recruitment, Patient retention is a key challenge facing most clinical studies.

This introductory workshop will identify and discuss factors which can enhance both Patient Recruitment and Patient Retention in Clinical Studies. Together with your team of Clinical Trial Specialists, we will be exploring if, and how innovative communication methods can be incorporated into your existing procedures in order to reduce Patient drop-out and thus to keep your Trial within timelines and budget.
Focus in this workshop will be on how online communication pathways to both Investigators and Trial Participants can strengthen Site and Patient relationships.

Experience from ‘general’ online Communities will be shared to explore how this might benefit Patient motivation in a study.

We will discuss “do’s” and “don’t” when using online Communication tools, especially when communicating to Trial Subjects. We will show examples of what might work (and what doesn’t), and how to fit this into your regulatory requirements.

For whom?

This workshop is intended for anybody involved in:
• Study Design & Setup
• Marketing & Communication
• Site & Patient Management
• Data Management
• Regulatory

The duration of this introductory workshop is 2 hours and is held as in-house course. The ideal number of participants is around 6 to 12. Cost is € 550 per workshop (a discount for academic or not-for-profit research groups might apply).

Workshop leaders

Innovation is all about combining knowledge from separate niches into something new.

Sjouke Huisman has over 20 years experience in Clinical Trials and medical research.

Jurjan Huisman has been responsible for Community Management at large ‘non-pharma’ companies.